Abstract
Paclitaxel is the prototype of a new class of chemotherapeutic agents with an antimitotic effect that is related to its ability to interfere with the microtubule system. It causes peripheral neurological toxicity by means of its activity on the axonal microtubules. To define the clinical and neurophysiological characteristics of paclitaxel neuropathy 23 patients undergoing paclitaxel therapy at a dose of 175 mg/m2 were studied. The patients were divided into two groups, with only one group receiving pretreatment with potentially neurotoxic drugs such as cisplatin and carboplatin. The results showed a high incidence of mild neurotoxicity in both groups. The clinical and neurophysiological data make it possible to define paclitaxel neurotoxicity as a distal axonal neuropathy with a summatory effect in patients pretreated with cisplatin; the possible reversibility of paclitaxel neurotoxicity requires further confirmation.
Original language | English |
---|---|
Pages (from-to) | 73-79 |
Number of pages | 7 |
Journal | Italian Journal of Neurological Sciences |
Volume | 18 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1997 |
Keywords
- distal axonopathy
- neurotoxicity
- paclitaxel
- platinum-compounds
ASJC Scopus subject areas
- Neuroscience(all)
- Clinical Neurology
- Psychiatry and Mental health
- Dermatology